Optimind Pharma Corp. (CSE:OMND)
0.0050
-0.0050 (-50.00%)
Aug 19, 2025, 1:59 PM EST
Optimind Pharma Company Description
Optimind Pharma Corp. provides psychedelic therapies in Canada.
The company offers treatment of post-traumatic stress syndrome, anxiety, depression, and other mental illnesses and disabilities through ketamine-assisted treatment and other psychedelic enhanced psychotherapy modalities.
It also provides cannabis referrals. In addition, the company operates clinics.
Optimind Pharma Corp. is headquartered in Toronto, Canada.
Optimind Pharma Corp.
| Country | Canada |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| CEO | David Goodman |
Contact Details
Address: 77 King Street West Toronto, ON M5K 1G8 Canada | |
| Phone | 647-891-9379 |
| Website | optimindpharma.com |
Stock Details
| Ticker Symbol | OMND |
| Exchange | Canadian Securities Exchange |
| Fiscal Year | March - February |
| Reporting Currency | CAD |
| ISIN Number | CA68405U1012 |
| SIC Code | 8000 |
Key Executives
| Name | Position |
|---|---|
| David Goodman | Chief Executive Officer and Director |
| Rakesh Malhotra (US), B.Com., C.A., C.P.A., CA (Canada), F.C.A., F | Chief Financial Officer and Secretary |